Publisert 18.10.2017

New SME Instrument 2 application submitted

October 18th 2017, Regenics submits its second  SME Instruments 2 funding application for Vernex® in psoriasis based on EU Commision Seal of Excellence" project obtained July 17th 2017.

The SME Instruments 2 research program is a highly competitve option for SME funding to leading near market projects.  Regenics has today October 18th 2017 submitted an application with a.o. Curida AS, Histocenter AB, Sweden and Dept of Dermatology , University of Michigan, US as subcontractors, for development of a CE marked psoriasis device. The total project budget is 1,9 mill Euro equivalent to  million NOK. The project period will cover funding from 2018 - 2019, including option for extension to 2021.

The application is based on the recently awarded "Seal of Excellence" rating above treshold in the Horizon 2020 SME Instruments 2 funding scheme.

The SME Instruments 2 program see fierce competition for funding every year and very few, often only one or two projects can  recieve funding. 


Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.